LLY

Eli Lilly & Co
D

LLY

920.40
USD
-6.39
(-0.69%)
Market Closed
Volume
82,728
EPS
34
Div Yield
0.67
P/E
40
Market Cap
822,246,169,368
OverviewSignalsNews
Signals
Moustafa El khaldy
Moustafa El khaldy
1 year ago
buy
LLY
LLY @823.59
2025-03-12 08:30
LLY@823.59 Chart
Profit
5,008.00
12.16%
Moustafa El khaldy
Moustafa El khaldy
7 months ago
buy
LLY
LLY @736.03
2025-08-27 07:11
LLY@736.03 Chart
Profit
4,494.00
12.21%
Moustafa El khaldy
Moustafa El khaldy
1 year ago
buy
LLY
LLY @737.88
2025-04-07 10:10
LLY@737.88 Chart
Profit
7,313.50
19.82%
Moustafa El khaldy
Moustafa El khaldy
1 year ago
buy
LLY
LLY @844.23
2025-02-17 11:21
LLY@844.23 Chart
Profit
3,513.00
8.32%
More
Related Instruments
ABBV
ABBV
203.750 USD
-4.610
(-2.21%)
AMGN
AMGN
350.11 USD
-5.12
(-1.44%)
BMY
BMY
59.115 USD
-1.055
(-1.75%)
GILD
GILD
135.880 USD
-1.750
(-1.27%)
GSK
GSK
57.355 USD
-0.995
(-1.71%)
JNJ
JNJ
230.590 USD
-3.600
(-1.54%)
MRK
MRK
117.090 USD
-1.980
(-1.66%)
PFE
PFE
27.520 USD
-0.040
(-0.15%)
SNY
SNY
47.975 USD
-0.080
(-0.17%)
ZTS
ZTS
122.690 USD
0.300
(0.25%)
More
News
ArincenArincen
AMGN
TSLA
NVDA
GOOG
AMZN
AMD
SMCI
LLY
2 months ago

Market Roundup: What Happened Yesterday and What Awaits Us Today (February 5)

ArincenArincen
NVO
LLY
EURUSDEURUSD
USDJPYUSDJPY
GBPUSDGBPUSD
USDCADUSDCAD
NZDUSDNZDUSD
USDCHFUSDCHF
3 months ago

Novo Nordisk Shares Soar as FDA Clears First Weight-Loss Pill

ArincenArincen
NVO
LLY
DKKTRYDKKTRY
HKDDKKHKDDKK
GBPDKKGBPDKK
DKKZARDKKZAR
DKKXDRDKKXDR
DKKUSDDKKUSD
7 months ago

Novo Nordisk Cuts 9,000 Jobs as Obesity Drug Battle Intensifies

More

Title: Eli Lilly & Co

Sector: Healthcare
Industry: Drug Manufacturers - General
Eli Lilly and Company researches, develops, manufactures, and sells pharmaceutical products for humans and animals. This American multinational pharmaceutical firm has its company headquarters in Indianapolis, Indiana. It also has branch locations in 18 countries around the world. Its products find their way into markets in roughly 125 countries globally. Some of the firm’s marquee pharmaceutical brands include the clinical depression drug Prozac and the antipsychotic medication Zyprexa. The company has been ranked in the top 150 firms of the Fortune 500 list of top American companies by revenue.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android
Social Network
The NetworkSignals NetworkIdeas NetworkBest TradersUser Reviews for Brokers
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHouse rulesHelp Centeradvertising with ArincenOur servicesReferral programDownload Mobile App
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.